<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: Baker Brothers Life Sciences LP -->
          <cik>0001363364</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001603454</issuerCik>
      <issuerName>Celcuity Inc.</issuerName>
      <secFileNumber>001-38207</secFileNumber>
      <issuerAddress>
        <com:street1>2800 Campus Drive</com:street1>
        <com:street2>Suite 140</com:street2>
        <com:city>Minneapolis</com:city>
        <com:stateOrCountry>MN</com:stateOrCountry>
        <com:zipCode>55441</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>763-392-0123</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Baker Brothers Life Sciences, L.P.</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Former Affiliate</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>Goldman Sachs &amp; Co. LLC</name>
        <address>
          <com:street1>200 West Street</com:street1>
          <com:city>New York</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>10282</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>2838632</noOfUnitsSold>
      <aggregateMarketValue>290959780.00</aggregateMarketValue>
      <noOfUnitsOutstanding>48766288</noOfUnitsOutstanding>
      <approxSaleDate>07/14/2026</approxSaleDate>
      <securitiesExchangeName>NASDAQ</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <acquiredDate>05/16/2025</acquiredDate>
      <natureOfAcquisitionTransaction>Purchases of shares of common stock in the open market See Remark 2</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Purchases from counterparties in open market transactions</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>2838632</amountOfSecuritiesAcquired>
      <paymentDate>05/19/2025</paymentDate>
      <natureOfPayment>Cash</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <remarks>(1) Baker Brothers Life Sciences, L.P. is affiliated with 667, L.P. Baker Bros. Advisors LP is the investment adviser to 667, L.P. and Baker Brothers Life Sciences, L.P. 667, L.P. is filing separately for the sale of 261,368 shares of common stock ("Common Stock") of Celcuity Inc. (the "Issuer"), which along with the reported sales in this form by Baker Brothers Life Sciences, L.P. totals 3,100,000 shares of Common Stock. (2) Shares of common stock to be sold were purchased between 5/16/2025 and 12/13/2024 in various open market transactions.</remarks>
    <noticeSignature>
      <noticeDate>07/14/2026</noticeDate>
      <signature>By: BAKER BROS. ADVISORS LP, mgmt company and IA to Baker Brothers Life Sciences, L.P., /s/ Scott L. Lessing, President</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
